阻塞性睡眠呼吸暂停患者阿尔茨海默病风险:治疗与否的真实世界证据
基于台湾全民健康保险研究数据库的回顾性队列研究,纳入3978例新诊断OSA患者与15912例匹配非OSA患者。调整后Cox模型显示OSA与AD发病率升高独立相关(aHR 2.12,95%CI 1.27-3.56),接受CPAP或手术治疗者AD风险显著低于未治疗者(IRR 0.23,95%CI 0.06-0.98)。
要点
- OSA与阿尔茨海默病风险升高独立相关(aHR 2.12)。
- CPAP或手术治疗可降低OSA患者的AD风险(IRR 0.23)。
- OSA可作为延缓或预防AD的潜在可干预靶点。
核心结论
- OSA与AD风险升高独立相关,治疗OSA可降低AD风险。
研究设计与样本
- 回顾性队列研究,使用台湾全民健康保险研究数据库识别1997-2012年新诊断OSA患者,按1:4匹配无OSA对照,随访至死亡或2013年底。
- 共纳入3978例OSA患者和15912例非OSA患者。
主要发现
- 调整后Cox比例风险模型显示OSA与AD发病率升高独立显著相关(aHR 2.12;95%CI 1.27-3.56)。
- 从OSA发生到检测到AD的平均时间为5.44年(标准差2.96)。
- 亚组分析显示OSA效应在年龄≥60岁、男性、未接受CPAP或手术治疗、未接受药物治疗的患者中仍显著。
- 接受治疗(CPAP或手术)的OSA患者AD风险显著低于未治疗者(发病率比0.23,95%CI 0.06-0.98)。
临床怎么用
- 对OSA患者应积极评估认知功能并考虑AD风险。
- CPAP或手术治疗可能降低OSA患者AD风险,可作为干预策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risk of Alzheimer's disease (AD) in patients with obstructive sleep apnea (OSA) with or without treatment based on real-world evidence. STUDY DESIGN: Retrospective cohort study. METHODS: Patients newly diagnosed with OSA during 1997-2012 were identified using the National Health Insurance Research Database of Taiwan. Patients without OSA were randomly selected and matched in a 1:4 ratio by age, sex, urbanization level, and income. All patients were followed up until death or the end of 2013. The primary outcome was AD occurrence. RESULTS: This study included 3,978 OSA patients and 15,912 non-OSA patients. OSA was independently and significantly associated with a higher incidence of AD in an adjusted Cox proportional hazard model (adjusted hazard ratio: 2.12; 95% confidence interval [CI], 1.27-3.56). The average period of AD detection from the time of OSA occurrence was 5.44 years (standard deviation: 2.96). Subgroup analyses revealed that the effect of OSA remained significant in patients aged ≥60 years, male subgroups, patients without CPAP or surgical treatment, and patients without pharmacological therapies. Patients with OSA who received treatment (continuous positive airway pressure or surgery) exhibited a significantly reduced risk of AD compared with those without treatment (incidence rate ratio 0.23, 95% CI, 0.06-0.98). CONCLUSION: OSA is independently associated with an increased risk of AD. Treatment for OSA reduces the AD risk in OSA patients. AD irreversibility renders OSA as a potential modifiable target for slowing or preventing the process of AD development. LEVEL OF EVIDENCE: IV Laryngoscope, 130:2292-2298, 2020.
引用
- Tsai MS, Li HY, Huang CG, et al. Risk of Alzheimer's Disease in Obstructive Sleep Apnea Patients With or Without Treatment: Real-World Evidence. Laryngoscope. 2020. PMID: 32045010. doi:10.1002/lary.28558
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。